S

Svas Biosana SpA
MIL:SVS

Watchlist Manager
Svas Biosana SpA
MIL:SVS
Watchlist
Price: 8.96 EUR -0.22% Market Closed
Market Cap: €47.8m

EV/OCF

-107.5
Current
1 520%
Cheaper
vs 3-y average of 7.6

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
-107.5
=
Enterprise Value
€59.1m
/
Operating Cash Flow
€-552.7k

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
-107.5
=
Enterprise Value
€59.1m
/
Operating Cash Flow
€-552.7k

Valuation Scenarios

Svas Biosana SpA is trading above its 3-year average

If EV/OCF returns to its 3-Year Average (7.6), the stock would be worth €-0.63 (107% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-112%
Maximum Upside
No Upside Scenarios
Average Downside
109%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple -107.5 €8.96
0%
3-Year Average 7.6 €-0.63
-107%
5-Year Average 7.6 €-0.63
-107%
Industry Average 12.6 €-1.05
-112%
Country Average 11.1 €-0.92
-110%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
IT
Svas Biosana SpA
MIL:SVS
47.5m EUR -107.5 7
US
Medline Inc
NASDAQ:MDLN
62B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 36.3 38.7
CH
Alcon AG
SIX:ALC
29.4B CHF 17.6 37.7
DK
Coloplast A/S
CSE:COLO B
95.4B DKK 16.8 24.1
US
Align Technology Inc
NASDAQ:ALGN
14B USD 21.7 34.1
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 15.8 34.3
CA
Bausch + Lomb Corp
NYSE:BLCO
5.7B USD 36.5 -15.7
KR
HLB Inc
KOSDAQ:028300
8T KRW -86.9 -36.4
JP
Asahi Intecc Co Ltd
TSE:7747
868.9B JPY 20.3 49.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD 14.3 22.9
P/E Multiple
Earnings Growth PEG
IT
S
Svas Biosana SpA
MIL:SVS
Average P/E: 31
7
15%
0.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.7
15%
2.6
CH
Alcon AG
SIX:ALC
37.7
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.1
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
34.1
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
34.3
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.7 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.4 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
49.1
40%
1.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
22.9
30%
0.8

Market Distribution

Lower than 100% of companies in Italy
Percentile
0th
Based on 752 companies
0th percentile
-107.5
Low
0.7 — 7
Typical Range
7 — 14.7
High
14.7 —
Distribution Statistics
Italy
Min 0.7
30th Percentile 7
Median 11.1
70th Percentile 14.7
Max 4 040.2

Svas Biosana SpA
Glance View

Market Cap
47.8m EUR
Industry
Health Care

Svas Biosana SpA distributes medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 367 full-time employees. The company went IPO on 2021-12-09. The firm consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The firm is the subsidiary of Svas group. Test Data.

SVS Intrinsic Value
14.82 EUR
Undervaluation 40%
Intrinsic Value
Price €8.96
S
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett